Increased transforming growth factor-β2 in epidermal growth factor receptor variant III-positive glioblastoma
- 1 June 2011
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 18 (6) , 821-826
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The EGFRvIII variant in glioblastoma multiformeJournal of Clinical Neuroscience, 2009
- EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in GlioblastomaCancer Research, 2009
- Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant gliomaSeminars in Immunology, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Transforming growth factor-beta (TGF-β) and brain tumoursJournal of Clinical Neuroscience, 2008
- Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patientsCytokine, 2007
- BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cellsCell Death & Differentiation, 2005
- The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-?, T-cell apoptosis, and the immune privilege of the brainBrain Research Reviews, 1995
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Transforming growth factor‐β2 down‐regulates HLA‐DR antigen expression on human malignant glioma cells.European Journal of Immunology, 1988